Saffron Academy · Preclinical research
A 2025 study in the Journal of Ethnopharmacology explored saffron extract and two of its compounds in a mouse model of high cholesterol. The findings concern experimental mechanisms, rather than a demonstrated treatment for people.
What did the researchers study?
C57BL/6 mice received a normal or high-fat diet, with experimental groups receiving saffron extract, crocin, crocetin or atorvastatin over 12 weeks. The study also used molecular modelling and other methods to investigate interactions with PCSK9.
Why PCSK9 matters
PCSK9 is involved in the regulation of LDL receptors, which help remove LDL cholesterol from the circulation. The research examined this pathway alongside sortilin, LDLR and SREBP-related signalling.
What was reported?
The authors reported improvements in lipid and liver-related measures in treated mice, lower PCSK9 and sortilin expression, and higher LDLR expression. Crocetin reduced plasma PCSK9 secretion by 39.9% in this experimental setting. That result belongs to crocetin under the study protocol; it is not a claim that culinary saffron produces the same reduction in people.
A controlled mouse model helps researchers explore mechanisms. It cannot establish an effective human dose, long-term safety, prevention of heart disease or equivalence to prescribed cholesterol medicines.
How should readers interpret the findings?
The results provide a direction for further research. Extracts and isolated compounds are different from saffron threads used in a meal or drink. Molecular binding results likewise do not prove a clinical benefit.
The earlier description of saffron as an affordable alternative to cholesterol medicines went beyond the evidence. This article therefore distinguishes the experimental findings from treatment claims.
Traditional use can explain why an ingredient attracts research interest, but it does not confirm the effectiveness of every proposed use. People taking prescribed medicines should not replace or adjust them on the basis of a preclinical study.
Continue reading
- Saffron and cholesterol: a separate preclinical study
- Saffron research and evidence
- Understanding saffron quality
Study reference
Siddiq A and colleagues (2025), Journal of Ethnopharmacology, 346, 119697. Original publisher record · PubMed record · DOI: 10.1016/j.jep.2025.119697.